메뉴 건너뛰기




Volumn 7, Issue 4, 2001, Pages 279-283

Her-2/neu gene amplification compared with HER-2/neu protein overexpression on ultrasound guided core-needle biopsy specimens of breast carcinoma

Author keywords

Breast carcinoma; FISH; Her 2 neu; Immunohistochemistry

Indexed keywords

MONOCLONAL ANTIBODY;

EID: 0035716542     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03032384     Document Type: Article
Times cited : (6)

References (21)
  • 7
    • 0029884715 scopus 로고    scopus 로고
    • Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization
    • (1996) Oncogene , vol.13 , pp. 63-72
    • Pauletti, G.1    Godolphin, W.2    Press, M.F.3
  • 8
    • 0033738879 scopus 로고    scopus 로고
    • Comparative methodological analysis of erbB-2/HER-2 gene dosage, chromosomal copy number and protein overexpression in breast carcinoma tissues for diagnostic use
    • (2000) Histopathol , vol.37 , pp. 411-419
    • Bankfalvi, A.1    Simon, R.2    Brandt, B.3
  • 13
    • 0345563219 scopus 로고    scopus 로고
    • The combination of in situ hybridization and immunohistochemical analysis: An evaluation of Her2/neu expression in paraffin-embedded breast carcinomas and adjacent normal appearing breast epithelium
    • (1997) Mod Pathol , vol.10 , pp. 1247-1252
    • Ratcliffe, N.1    Wells, W.2    Wheeler, K.3
  • 19
    • 0031759864 scopus 로고    scopus 로고
    • The HER-2/neu oncogene in breast cancer: Prognostic factor, predictive factor, and target for therapy
    • (1998) Stem Cells , vol.16 , pp. 413-428
    • Ross, J.S.1    Fletcher, J.A.2
  • 20
    • 0028232729 scopus 로고
    • Sensitivity of HER-2/neu antibodies in archival tissue samples: Potential source of error in immunohistochemical studies of oncogene expression
    • (1994) Cancer Res , vol.54 , pp. 2771-2777
    • Press, M.F.1    Hung, G.2    Godolphin, W.3
  • 21
    • 0035873962 scopus 로고    scopus 로고
    • Discrepancies in clinical laboratory testing of eligibility for transtuzumab therapy: Apparent immunohistochemical false positives do not get the message
    • (2001) J Clin Oncol , vol.15 , pp. 2714-2721
    • Tubbs, R.R.1    Pettay, J.D.2    Roche, P.C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.